Insud Pharma launches Chemostart IX edition, programme aimed at innovative start-ups in biotechnology and human health
Insud Pharma lanza Chemostart edición IX, programa dirigido a startups innovadoras en biotecnología y salud humana
Intel ID : 425529
|
||||
| Intel ID | 425529 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Insud Pharma
(31 Dec 2019) |
Revenue: EUR 44,52m People: 147 |
|
| Date |
 |
|
| Country |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
25.04.03 Holding Companies / Financial Holding Companies (Primary) 25 Financial Services / 25.04 Other Financial Services |
|
| Secondary Subsectors (TTRSC) |
25.01.10 Venture Capital 25 Financial Services / 25.01 Banking & Investment |
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.04.03 Holding Companies / Financial Holding Companies 25 Financial Services / 25.04 Other Financial Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.